Gene · 23308
Papers2,855
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 2,855
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Integrating human plasma proteomes with genome-wide association data implicates novel proteins and drug targets for rheumatoid arthritis. | Clin Proteomics | 2026 | 41540382 | PubTator, text mining | PubMed |
| Matrix Type Influences the Levels of Soluble Immune Checkpoints. | J Clin Lab Anal | 2026 | 41460822 | PubTator, text mining | PubMed |
| miR-155 aberrant expression impairs tumor rejection because of its targeting of ICOSL and multiple pathways implicated in the antitumor response. | Pharmacol Rev | 2026 | 41289737 | PubTator, text mining | PubMed |
| A Multi-omics Framework Combining Genomics and Proteomics for Silicosis Prediction in Chinese Workers - Jiangsu Province, China, 2023-2024. | China CDC Wkly | 2025 | 42239641 | PubTator, text mining | PubMed |
| Macrophage-Dendritic Cell-T-Cell Tetrads Orchestrate Antitumor Immunity and Response to Checkpoint Blockade. | bioRxiv | 2025 | 41509466 | PubTator, text mining | PubMed |
| Diagnostic potential of soluble and membrane-bound inducible T-cell co-stimulator in Sjögren's disease. | Clin Exp Rheumatol | 2025 | 41410584 | PubTator, text mining | PubMed |
| ICOSL: more than a trigger of ICOS function. | Cell Commun Signal | 2025 | 41299676 | PubTator, text mining | PubMed |
| The influencing factors of chronic obstructive pulmonary disease concomitant with pulmonary heart disease and the diagnostic value of myocardial markers. | Biomed Eng Online | 2025 | 41299633 | PubTator, text mining | PubMed |
| Interpretable machine learning applied to high-dimensional salivary proteomics accurately classifies pediatric inflammatory bowel diseases. | medRxiv | 2025 | 41282744 | PubTator, text mining | PubMed |
| CST7+ macrophages/monocytes in melanoma: single-cell insights into immunotherapy response. | Transl Cancer Res | 2025 | 41234849 | PubTator, text mining | PubMed |
| Construction of a prognostic model for nasopharyngeal carcinoma based on serum exosomal circular RNAs and analysis of immune microenvironment. | Clin Exp Med | 2025 | 41217541 | PubTator, text mining | PubMed |
| High-dimensional spectral cytometry identifies follicular regulatory CD8+ T cells in diffuse large B-cell lymphoma. | Clin Transl Immunology | 2025 | 41190308 | PubTator, text mining | PubMed |
| Follicular helper T cells (Tfh): heterogeneity in spatial distribution and phenotypic characteristics. | Front Immunol | 2025 | 41181158 | PubTator, text mining | PubMed |
| Enhanced ICOS Signaling Between Dendritic Cells and T Cells Characterizes the Immune Landscape of Human Cholangiocarcinoma. | Hum Mutat | 2025 | 41180156 | PubTator, text mining | PubMed |
| Malignant cell-mediated Treg immune suppression via ICOSLG-ICOS axis in tumor microenvironment relates to nasopharyngeal carcinoma prognosis. | Int Immunopharmacol | 2025 | 41151481 | PubTator, text mining | PubMed |
| Deciphering tumor-intrinsic and immune characteristics in resectable non-small cell lung cancer treated with neoadjuvant pembrolizumab and chemotherapy. | J Transl Med | 2025 | 41088357 | PubTator, text mining | PubMed |
| Cell-Selective Targeting Chimeras (SelecTACB) for Membrane Protein Degradation on B Cells. | J Am Chem Soc | 2025 | 41004276 | PubTator, text mining | PubMed |
| The B7 family molecules in oral squamous cell carcinoma: a systematic review. Part II: B7-1, B7-2, B7-H2, B7-H3, B7-H4, B7-H5 (VISTA), B7-H6 and B7-H7. | Postepy Dermatol Alergol | 2025 | 41001137 | PubTator, text mining | PubMed |
| Liquid biomarkers associate with TGF-β Type I receptor and hypoxia in kidney cancer. | Signal Transduct Target Ther | 2025 | 40998794 | PubTator, text mining | PubMed |
| Exploration of potential novel drug targets for rheumatoid arthritis by plasma proteome screening. | PLoS Comput Biol | 2025 | 40996951 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/23308/papers?page=3